Data / Form D filings / Applied Therapeutics, Inc.
Applied Therapeutics, Inc.: Form D filings
Applied Therapeutics, Inc., a biotechnology company in New York, NY, filed 6 Form D notices with the SEC between 2017 and 2024. The latest, on March 13, 2024, reports $100 million sold of a $100 million offering to 31 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 545 FIFTH AVENUE, SUITE 1400, New York, NY, 10017
- Phone
- (212) 220-9226
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1697532
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 13, 2024 | New notice | $99,997,998 | $99,997,998 | 31 | Feb 27, 2024 | sec.gov | |
| May 5, 2023 | New notice | $30,000,002 | $30,000,002 | 19 | Apr 23, 2023 | sec.gov | |
| Nov 21, 2019 | New notice | $20,014,988 | $20,014,988 | 12 | Nov 7, 2019 | sec.gov | |
| Nov 19, 2018 | New notice | $56,584,093 | $27,158,092 | $29,426,001 | 37 | Nov 5, 2018 | sec.gov |
| Feb 20, 2018 | New notice | $6,000,000 | $6,000,000 | 23 | Feb 8, 2018 | sec.gov | |
| Feb 8, 2017 | New notice | $7,000,000 | $6,067,875 | $932,125 | 26 | Jan 26, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Riccardo Perfetti | Executive Officer | |
| Adam Hansard | Executive Officer | |
| Stacy J. Kanter | Director | |
| Catherine Thorpe | Executive Officer | |
| Les Funtleyder | Executive Officer, Director | |
| Joel S. Marcus | Director | |
| Shoshana Shendelman | Executive Officer, Director | |
| Teena J. Lerner | Director | |
| Jay S. Skyler | Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Mar 11, 2024 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Applied Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.